Fastum (Fastum Gel),25 mg/g, gel
Ketoprofen
Fastum and Fastum Gel are different trade names for the same drug.
Fastum is a medicine from the group of non-steroidal anti-inflammatory and analgesic drugs
for topical use.
Ketoprofen - the active substance of Fastum - administered topically, is absorbed through the skin into
inflamed areas of joints, tendons, ligaments, and muscles. It does not accumulate in the body.
The gel, thanks to its water-alcohol base, also has a surface cooling and soothing effect.
The base ensures proper release of ketoprofen and minimal risk of systemic side effects. The medicine is well tolerated even in
cases of sensitive skin.
The gel should not be used on damaged or diseased skin, e.g. in the case of eczema,
acne, skin infections or open wounds.
Due to the lack of controlled clinical trials on the efficacy and safety of
using ketoprofen in children, this medicine should not be used in children under 15 years of age.
Exposure to sunlight (even when the sky is cloudy) or UVA rays on
skin areas where Fastum has been applied may cause severe skin reactions
(hypersensitivity to sunlight). Therefore, it is necessary:
No interactions between Fastum and other medicines have been reported. However, caution should be exercised in patients taking oral anticoagulant medicines at the same time.
If the patient is pregnant or breastfeeding, suspects that she may be pregnant or plans to have
a child, she should consult her doctor or pharmacist before using this medicine.
Using non-steroidal anti-inflammatory drugs (NSAIDs) during the third trimester of pregnancy may
have a harmful effect on the fetus's heart and lungs. Non-steroidal anti-inflammatory drugs may
cause delayed delivery.
Fastum should not be used if the patient is in the last 3 months of pregnancy. During the first 6 months of pregnancy, Fastum should not be taken unless the doctor considers its use absolutely necessary. If treatment is necessary during this period, the smallest possible dose should be used for the shortest possible time.
Oral forms (e.g. tablets) of ketoprofen may cause side effects in the unborn child. It is not known whether the same risk occurs when using Fastum on the skin.
Before using any medicine, you should consult your doctor.
Ketoprofen passes into breast milk in small amounts. It is not recommended to give the medicine to women during breastfeeding.
The effect of the medicine on the ability to drive and use machines has not been described.
The medicine contains flavoring substances with citral, citronellol, coumarin, farnesol, geraniol,
d-limonene and linalool. They may cause allergic reactions.
In patients with a history of epilepsy, caution should be exercised when using the medicine due to the presence of a terpene derivative (lavender flavor) in the product.
Fastum is used 1 to 2 times a day, a thin layer of gel (a strip of gel 3 cm to 5 cm long) should be applied to the skin in the painful area and gently massaged to facilitate absorption. If after 7 days of using the medicine the symptoms do not disappear, worsen or new symptoms occur, you should consult a doctor.
Fastum should not be used in children under 15 years of age.
No cases of overdose or poisoning with Fastum have been reported.
In case of accidental ingestion of the gel, the following may occur: drowsiness, nausea, vomiting. Ingestion of large doses may cause respiratory depression, coma, convulsions,
gastrointestinal bleeding, increased or decreased blood pressure, acute renal failure.
The doctor will take appropriate measures and initiate symptomatic treatment usually used in the treatment of non-steroidal anti-inflammatory drug poisoning. If the overdose occurred no more than 1 hour ago, gastric lavage should be performed and symptomatic treatment should be administered.
Like all medicines, Fastum can cause side effects, although not everybody gets them.
Local skin reactions have been observed, which can then spread beyond the site of application of the medicine. Rarely, severe reactions such as blistering or pustular rash have occurred, which can spread or become generalized.
Other systemic side effects (e.g. related to the digestive system or kidneys) caused by non-steroidal anti-inflammatory drugs result from the absorption of the active substance of the medicine through the skin, and are therefore dependent on the amount of gel used, the treated skin surface, the degree of absorption into the tissue, the duration of treatment, and the possible use of an occlusive dressing (hypersensitivity, gastrointestinal disorders, and kidney function disorders).
The following frequencies of occurrence are usually the basis for assessing side effects:
Very common: more than 1 in 10 treated patients;
Common: less than 1 in 10 but more than 1 in 100 treated patients;
Uncommon: less than 1 in 100 but more than 1 in 1,000 treated patients;
Rare: less than 1 in 1,000 but more than 1 in 10,000 treated patients;
Very rare: less than 1 in 10,000 treated patients;
Unknown (frequency cannot be estimated from available data).
Classification of systems and organs | Uncommon (≥1/1,000 to <1> | Rare (≥1/10,000 to <1> | Very rare (<1> |
Immune system disorders | Anaphylactic reaction, hypersensitivity reactions | ||
Gastrointestinal disorders | Stomach and duodenal ulcer, gastrointestinal bleeding, diarrhea | ||
Skin and subcutaneous tissue disorders | Redness, itching, rash, burning | Sunlight hypersensitivity, blistering rash, urticaria | Contact dermatitis, angioedema |
Kidney and urinary disorders | Kidney failure or worsening of kidney function disorders |
Elderly patients are particularly at risk of side effects after taking non-steroidal anti-inflammatory drugs.
If any of the side effects worsen or any side effects not listed in this leaflet occur, you should inform your doctor or pharmacist.
If you experience any side effects, including any side effects not listed in the leaflet, you should tell your doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products
of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products
Jerozolimskie Avenue 181 C, 02-222 Warsaw, tel.: + 48 22 49 21 301, fax: + 48 22 49 21 309,
website: https://smz.ezdrowie.gov.pl.
By reporting side effects, you can help gather more information on the safety of the medicine.
There are no special precautions for storage.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
Shelf life after first opening the packaging: 6 months.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
A tube containing 50 g or 100 g of gel in a cardboard box.
For more detailed information, please contact the marketing authorization holder or the parallel importer.
InPharm Sp. z o.o.
Strumykowa 28/11
03-138 Warsaw
InPharm Sp. z o.o. Services sp. k.
Chełmżyńska 249
04-458 Warsaw
Pharma Innovations Sp. z o.o.
Jagiellońska 76
03-301 Warsaw
Authorization number in Romania, the country of export:8884/2016/03
8884/2016/04
Parallel import authorization number:175/19
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.